NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 400 shares, a decline of 99.4% from the March 31st total of 65,900 shares. Based on an average trading volume of 1,568,900 shares, the short-interest ratio is currently 0.0 days.
NovAccess Global Stock Performance
XSNX opened at $0.01 on Friday. The company has a market cap of $178,484.70, a P/E ratio of -0.05 and a beta of 1.51. The company’s 50 day moving average is $0.01 and its 200-day moving average is $0.03. NovAccess Global has a 1-year low of $0.01 and a 1-year high of $0.22.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last issued its earnings results on Tuesday, February 27th. The company reported $0.01 earnings per share for the quarter.
NovAccess Global Company Profile
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Featured Stories
- Five stocks we like better than NovAccess Global
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Hasbro’s Management Made All the Right Calls This Quarter
- The 3 Best Retail Stocks to Shop for in August
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How Can Investors Benefit From After-Hours Trading
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
